🚀 Medial Secures Investment on Shark Tank India - Fueling the Future of Professional Social Networking. 🔥
Login

News on Medial

OneCell Diagnostics raises $16 million in round led by Celesta Capital, others

Economic TimesEconomic Times · 1y ago
OneCell Diagnostics raises $16 million in round led by Celesta Capital, others
Medial

OneCell Diagnostics, a startup specializing in AI-powered cancer diagnostics, has raised $16 million in a series A funding round. The funding was led by Celesta Capital and included participation from Tenacity Ventures, Cedars Sinai, Eragon, and Singularity Ventures. OneCell plans to use the funds to expand to the US market with its liquid biopsy test, OncoIndx Alfa, which detects circulating tumor cells for precision diagnosis and treatment of cancer. The funding will also help the company democratize precision oncology by making cancer diagnostic testing more accessible and affordable. OneCell has already tested its technology in India and has partnerships with leading medical institutions.

Related News

Oncology startup 4baseCare raises Rs 90 Cr led by Ashish Kacholia and Lashit Sanghvi

EntrackrEntrackr · 5d ago
Oncology startup 4baseCare raises Rs 90 Cr led by Ashish Kacholia and Lashit Sanghvi
Medial

Precision oncology startup 4baseCare has raised Rs 90 crore ($9.8 million) in the first close of its Series B round co-led by Ashish Kacholia and Lashit Sanghvi, with participation from existing investor Yali Capital. The new round comes after a gap of two years. In 2024, the company had raised $6 million in Series A funding, led by Yali Capital, with participation from Infosys. The fresh capital will be used to expand 4baseCare’s hospital-linked genomics lab network across India, the Middle East, Southeast Asia, Latin America, and Central Asia. It will also scale its AI-powered precision oncology platform, OncoTwin, which supports clinical decision-making for cancer treatment. Founded by Hitesh Goswami, 4baseCare focuses on building population-relevant clinico-genomic datasets to improve cancer diagnosis and treatment outcomes in underrepresented populations. Its platform integrates genomic testing with real-world clinical and outcomes data to generate actionable insights for oncologists. The OncoTwin platform was recently selected for the MSK iHub program at Memorial Sloan Kettering Cancer Center, New York. The company works closely with hospitals to offer genomics-led cancer diagnostics within clinical settings and is positioning itself to scale across emerging markets. Investor interest in cancer-focused startups has picked up in recent years. Last year, Everhope Oncology raised $10 million in seed funding, and MOC Cancer Care & Research Centre secured $18 million led by Elevation Capital. ErlySign, OnCare, and OneCell Diagnostics are also among the funded startups.

5C Network raises $3 Mn in a new round

EntrackrEntrackr · 1y ago
5C Network raises $3 Mn in a new round
Medial

Medical diagnostics platform 5C Network has raised Rs 25.5 crore (approximately $3 million) from Redwood India Healthcare Fund in a new round. This is the first investment for the firm this year. The board at 5C Network has passed a special resolution to issue 2,72,241 CCSPS at an issue price of Rs 936.67 each to raise Rs 25.5 crore, its regulatory filing accessed from the Registrar of Companies shows. For background, the Bengaluru-based company has raised the proceeds after a gap of more than 17 months. 5C Network last raised $4.6 million in its Series A round led by Celesta Capital in Oct 2022. As per the startup data intelligence platform TheKredible estimates, the company has been valued at around $30 million (post-money). Founded in 2016 by Sivasailam and Syed Ahmed, 5C Network enables users across India to store, create, and analyse radiology images. It facilitates hospitals in maximizing returns on their radiology infrastructure by providing access to radiologists. With the backing of Tata 1mg and Celesta Capital, the firm has raised over Rs 80 crore to date. Before the fresh proceeds, Unitus Capital was the largest external stakeholder with 20.8% followed by Celeseta Capital and Tata 1mg. Its co-founders Kalyanasundaram S and Syed Sabbir Ahmed cumulatively commanded 33.9% of the company. 5C Network has been struggling with growth and this could be evident from its collection which dwindled by 20% to Rs 18.75 crore during the fiscal year ended March 2023. Moreover, the company posted Rs 19.47 crore loss during the same period.

Download the medial app to read full posts, comements and news.